S
NVO

SignatureFD’s Novo Nordisk NVO Stock Holding History

SignatureFD’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97M Sell
53,683
-7,558
-12% -$358K 0.03% 232
2025
Q4 		$3.12M Sell
61,241
-4,506
-7% -$230K 0.05% 153
2025
Q3 		$3.65M Sell
65,747
-10,234
-13% -$599K 0.06% 134
2025
Q2 		$5.24M Buy
75,981
+4,923
+7% +$335K 0.09% 75
2025
Q1 		$4.93M Sell
71,058
-5,049
-7% -$417K 0.09% 71
2024
Q4 		$6.55M Sell
76,107
-2,540
-3% -$275K 0.12% 58
2024
Q3 		$9.36M Buy
78,647
+316
+0.4% +$42.1K 0.18% 47
2024
Q2 		$11.2M Buy
78,331
+1,763
+2% +$234K 0.23% 38
2024
Q1 		$9.83M Buy
76,568
+3,429
+5% +$408K 0.21% 40
2023
Q4 		$7.57M Buy
73,139
+2,267
+3% +$224K 0.17% 49
2023
Q3 		$6.45M Buy
70,872
+5,690
+9% +$501K 0.17% 50
2023
Q2 		$5.27M Buy
65,182
+630
+1% +$51.5K 0.13% 58
2023
Q1 		$5.14M Buy
64,552
+1,610
+3% +$114K 0.14% 57
2022
Q4 		$4.26M Buy
62,942
+3,032
+5% +$178K 0.12% 61
2022
Q3 		$2.98M Sell
59,910
-154
-0.3% -$8.25K 0.1% 67
2022
Q2 		$3.35M Buy
60,064
+1,832
+3% +$102K 0.11% 63
2022
Q1 		$3.23M Buy
58,232
+2,898
+5% +$149K 0.1% 66
2021
Q4 		$3.1M Buy
55,334
+3,492
+7% +$189K 0.1% 76
2021
Q3 		$2.49M Buy
51,842
+2,272
+5% +$110K 0.09% 84
2021
Q2 		$2.08M Buy
49,570
+2,568
+5% +$99.5K 0.08% 96
2021
Q1 		$1.58M Buy
47,002
+2,788
+6% +$99.3K 0.07% 106
2020
Q4 		$1.54M Buy
44,214
+1,454
+3% +$50.3K 0.07% 92
2020
Q3 		$1.48M Buy
42,760
+810
+2% +$27K 0.08% 90
2020
Q2 		$1.37M Buy
41,950
+1,096
+3% +$35K 0.08% 85
2020
Q1 		$1.23M Buy
40,854
+3,076
+8% +$91.6K 0.11% 76
2019
Q4 		$1.09M Buy
37,778
+2,136
+6% +$59.1K 0.08% 109
2019
Q3 		$921K Buy
35,642
+3,538
+11% +$89.5K 0.08% 108
2019
Q2 		$819K Buy
32,104
+2,250
+8% +$55.6K 0.07% 109
2019
Q1 		$781K Buy
29,854
+3,520
+13% +$86.5K 0.07% 120
2018
Q4 		$607K Buy
26,334
+4,102
+18% +$91.2K 0.06% 146
2018
Q3 		$524K Buy
22,232
+1,602
+8% +$39.1K 0.05% 188
2018
Q2 		$476K Buy
20,630
+1,044
+5% +$24.8K 0.05% 183
2018
Q1 		$482K Buy
19,586
+4,854
+33% +$127K 0.06% 154
2017
Q4 		$395K Buy
14,732
+2,368
+19% +$60.2K 0.05% 184
2017
Q3 		$298K Buy
12,364
+1,492
+14% +$33.7K 0.04% 209
2017
Q2 		$233K Sell
10,872
-2,520
-19% -$50.9K 0.03% 235
2017
Q1 		$230K Buy
+13,392
New +$233K 0.03% 241
2016
Q4 		– Sell
-4,284
Closed -$89K – 882
2016
Q3 		$89K Buy
4,284
+920
+27% +$22.8K 0.01% 391
2016
Q2 		$90K Buy
3,364
+534
+19% +$14.6K 0.01% 327
2016
Q1 		$77K Buy
2,830
+60
+2% +$1.61K 0.01% 340
2015
Q4 		$80K Buy
2,770
+816
+42% +$22.6K 0.02% 278
2015
Q3 		$53K Buy
1,954
+1,200
+159% +$34K 0.01% 334
2015
Q2 		$21K Buy
754
+374
+98% +$10.5K ﹤0.01% 464
2015
Q1 		$10K Buy
380
+38
+11% +$875 ﹤0.01% 533
2014
Q4 		$7K Buy
+342
New +$7.64K ﹤0.01% 551
2014
Q3 		– Sell
-268
Closed -$6K – 851
2014
Q2 		$6K Buy
+268
New +$5.92K ﹤0.01% 559

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

SignatureFD's NVO Position: Q1 2026 in Review

SignatureFD reduced its Novo Nordisk (NVO) stake by 12% in Q1 2026, selling an estimated $358K and leaving 53,683 shares worth $1.97M. The position accounts for 0.03% of the portfolio, ranked #232.

SignatureFD first reported a position in NVO in Q2 2014 and has held it in 46 quarters since. The position peaked at $11.2M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • SignatureFD held 53,683 shares of Novo Nordisk worth $1.97M as of Q1 2026.
  • SignatureFD sold 7,558 Novo Nordisk shares in Q1 2026, an estimated $358K.
  • Novo Nordisk made up 0.03% of SignatureFD's portfolio in Q1 2026, its #232 holding.
  • SignatureFD first reported a position in Novo Nordisk in Q2 2014 and has held it in 46 quarters since.
  • SignatureFD's Novo Nordisk position peaked at $11.2M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.